Type Società per azioni Industry Biotechnology Headquarters Italy Founded 1968 | Traded as BIT: DIA Website www.diasorin.com Revenue 443.8 million EUR (2014) Number of employees 1,620 | |
 | ||
Key people Gustavo Denegri (Chairman)
Carlo Rosa (CEO) Products In vitro diagnostics instruments and services Stock price DIA (BIT) € 60.00 +0.20 (+0.33%)6 Mar, 5:29 PM GMT+1 - Disclaimer Parent organization American Standard Companies Subsidiaries DiaSorin Switzerland AG Profiles | ||
DiaSorin is an Italian multinational biotechnology company that produces and markets in vitro diagnostics reagent kits used in immunodiagnostics and molecular diagnostics. The group was founded in 1968 and is headquartered in Saluggia, Italy.
Contents
The production platform of the Group is now divided into several plants located in Europe, the United States and Africa: Saluggia, Dietzenbach (Germany), Stillwater, Minnesota (US), Dublin (Ireland), Dartford (UK) and Kyalami (South Africa).
The company is a constituent of the FTSE Italia Mid Cap index.
In March 2016, the company announced it would acquire Quest Diagnostics’ Focus Diagnostics immunodiagnostic and molecular diagnostic division for $300 million.
Activities
DiaSorin is focusing its efforts to 8 fields of immunodiagnostics: Infectious diseases, Bone and Mineral, Endocrinology, Hypertension, Oncology, Gastro-Intestinal infections, Autoimmunity and Brain and Cardiac markers.
The company is also active in molecular diagnostics for infectious diseases and for the detection of some forms of Leukemia.
Financial data
DiaSorin is listed since 2007 in the Italian Stock Exchange and today in the FTSE Italy Mid Cap Index.